Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001022855-14-000001
Filing Date
2014-07-30
Accepted
2014-07-30 16:11:59
Documents
1
Period of Report
2014-07-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4006
  Complete submission text file 0001022855-14-000001.txt   5422
Mailing Address CELLCOR INC 200 WELLS AVE NEWTON MA 02159
Business Address
MIESOWICZ FREDERICK (Reporting) CIK: 0001022855 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 141003011

Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

EIN.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations